BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 11768409)

  • 41. [How to treat ADHD/DAMP? Is there a conclusive answer? A critical survey of the MTA trial?].
    Hansen L; Thomsen PH
    Ugeskr Laeger; 2005 Nov; 167(48):4555-9. PubMed ID: 16324436
    [TBL] [Abstract][Full Text] [Related]  

  • 42. American Academy of Pediatrics Committee on Children with Disabilities, Committee on Drugs: Medication for children with an attention deficit disorder.
    Pediatrics; 1987 Nov; 80(5):758-60. PubMed ID: 3670981
    [No Abstract]   [Full Text] [Related]  

  • 43. [Methylphenidate of retard forms in children and adolescents with ADHD - an overview].
    Pelz R; Banaschewski T; Becker K
    Klin Padiatr; 2008; 220(2):93-100. PubMed ID: 18157763
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Attention deficit/hyperactivity disorder in adults.
    Moss SB; Nair R; Vallarino A; Wang S
    Prim Care; 2007 Sep; 34(3):445-73, v. PubMed ID: 17868755
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Drug therapy in the treatment of minimal brain dysfunction.
    Saccar CL
    Am J Hosp Pharm; 1978 May; 35(5):544-52. PubMed ID: 26219
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity.
    Research Units on Pediatric Psychopharmacology Autism Network
    Arch Gen Psychiatry; 2005 Nov; 62(11):1266-74. PubMed ID: 16275814
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder.
    Pliszka S;
    J Am Acad Child Adolesc Psychiatry; 2007 Jul; 46(7):894-921. PubMed ID: 17581453
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Attention deficit hyperactivity disorder, chronic tic disorder, and methylphenidate.
    Gadow KD; Sverd J
    Adv Neurol; 2006; 99():197-207. PubMed ID: 16536367
    [No Abstract]   [Full Text] [Related]  

  • 49. [Who is the hyperactive child?].
    Le Heuzey MF
    Soins Pediatr Pueric; 2005 Aug; (225):33-5. PubMed ID: 16134447
    [No Abstract]   [Full Text] [Related]  

  • 50. Drugged-out toddlers. A new study documents an alarming increase in behavior-altering medication for preschoolers.
    Kalb C
    Newsweek; 2000 Mar; 135(10):53. PubMed ID: 10847892
    [No Abstract]   [Full Text] [Related]  

  • 51. Current strategies in the diagnosis and treatment of childhood attention-deficit/hyperactivity disorder.
    Rader R; McCauley L; Callen EC
    Am Fam Physician; 2009 Apr; 79(8):657-65. PubMed ID: 19405409
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Relative benefits of stimulant therapy with OROS methylphenidate versus mixed amphetamine salts extended release in improving the driving performance of adolescent drivers with attention-deficit/hyperactivity disorder.
    Cox DJ; Merkel RL; Moore M; Thorndike F; Muller C; Kovatchev B
    Pediatrics; 2006 Sep; 118(3):e704-10. PubMed ID: 16950962
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Health-related quality of life in methylphenidate-treated children with attention-deficit-hyperactivity disorder: results from a Taiwanese sample.
    Yang P; Hsu HY; Chiou SS; Chao MC
    Aust N Z J Psychiatry; 2007 Dec; 41(12):998-1004. PubMed ID: 17999272
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Hyperkinetic disorders with attention deficit. Diagnostic and therapeutic approach].
    Vallée L; Pandit F
    Pediatrie; 1991; 46(11):719-29. PubMed ID: 1661401
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Increased urine phenylethylamine after methylphenidate treatment in children with ADHD.
    Kusaga A; Yamashita Y; Koeda T; Hiratani M; Kaneko M; Yamada S; Matsuishi T
    Ann Neurol; 2002 Sep; 52(3):372-4. PubMed ID: 12205654
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Attention-deficit/hyperactivity disorder (ADHS) in adulthood].
    Kordon A; Kahl KG
    Psychother Psychosom Med Psychol; 2004; 54(3-4):124-36. PubMed ID: 15037976
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Naturalistic long-term use of methylphenidate in bipolar disorder.
    Lydon E; El-Mallakh RS
    J Clin Psychopharmacol; 2006 Oct; 26(5):516-8. PubMed ID: 16974196
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Methylphenidate use for attention deficit hyperactivity disorder in northern Israel--a controversial issue.
    Fogelman Y; Kahan E
    Isr Med Assoc J; 2001 Dec; 3(12):925-7. PubMed ID: 11794916
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The diagnosis and treatment of attention deficit-hyperactivity disorder in children and adolescents with cystic fibrosis: a retrospective study.
    Georgiopoulos AM; Hua LL
    Psychosomatics; 2011; 52(2):160-6. PubMed ID: 21397109
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pemoline (Cylert) for minimal brain dysfunction.
    Med Lett Drugs Ther; 1976 Jan; 18(2):5-6. PubMed ID: 1107790
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.